Skip to main content

JANE STREET GROUP, LLC

Position in PYXS — Pyxis Oncology, Inc.

CIK 1595888 NEW YORK, NY

Position in PYXS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$873,170
+$428,661 QoQ
Shares Held
290,090
-4.7% QoQ
Ownership
0.348%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 76 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PYXS Over Time

Shares Held

Position Value (USD)

Derivatives in PYXS

reported options exposure · as of Jun 30, 2026
CallValue
$221,837
CallShares
73,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. PYXS ranks #89 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PYXS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $221,837 73,700
2026-06-30 $873,170 290,090
2026-03-31 $37,230 25,500
2026-03-31 $444,509 304,459
2025-12-31 $903,911 786,010
2025-09-30 $674,213 303,700
2025-06-30 $369,692 336,084
2024-12-31 $105,589 67,686
2024-09-30 $181,876 49,558
2024-06-30 $116,541 35,209
2024-03-31 $746,573 175,252
2023-12-31 $27,028 15,016
2023-03-31 $302,474 75,430